Free Access: Please Log In
This content is completely free—but you need to be logged in to read the full article. If you already have an account, please log in below. Otherwise, register for free to unlock instant access.
References (9)
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th edition, Text Revision. American Psychiatric Association; 2022.
- Hudson SM, Whiteside TE, Lorenz RA, et al. Prazosin for the treatment of nightmares related to posttraumatic stress disorder: a review of the literature. Prim Care Companion CNS Disord. 2012;14(2):11r01222. PubMed CrossRef
- Do Monte FH, Souza RR, Wong TT, et al. Systemic or intra-prelimbic cortex infusion of prazosin impairs fear memory reconsolidation. Behav Brain Res. 2013;244:137–141. PubMed CrossRef
- Basquez R, Pippin MM. Prazosin. In: StatPearls [Internet]. StatPearls Publishing; 2023. Accessed October 3, 2023. https://www.ncbi.nlm.nih.gov/books/NBK555959/
- Raskind MA, Peskind ER, Chow B, et al. Trial of prazosin for post-traumatic stress disorder in military veterans. N Engl J Med. 2018;378(6):507–517. PubMed CrossRef
- Singh B, Hughes AJ, Mehta G, et al. Efficacy of prazosin in posttraumatic stress disorder: a systematic review and meta-analysis. Prim Care Companion CNS Disord. 2016;18(4):16r01943
- Khachatryan D, Groll D, Booij L, et al. Prazosin for treating sleep disturbances in adults with posttraumatic stress disorder: a systematic review and meta-analysis of randomized controlled trials. Gen Hosp Psychiatry. 2016;39:46–52. PubMed CrossRef
- Prazosin (minipress) [Package Insert]. Pfizer Labs; 2009.
- Richardson C, Swartz A, Forsberg M. Prazosin dosed 3 times a day to treat flashbacks related to PTSD: a case report. Ment Health Clin:12(4):267–269. PubMed
Please sign in or purchase this PDF for $40.